146 related articles for article (PubMed ID: 38054534)
21. Cytokine-enhanced cytolytic activity of exosomes from NK Cells.
Enomoto Y; Li P; Jenkins LM; Anastasakis D; Lyons GC; Hafner M; Leonard WJ
Cancer Gene Ther; 2022 Jun; 29(6):734-749. PubMed ID: 34316033
[TBL] [Abstract][Full Text] [Related]
22. Optimization of Human NK Cell Manufacturing: Fully Automated Separation, Improved Ex Vivo Expansion Using IL-21 with Autologous Feeder Cells, and Generation of Anti-CD123-CAR-Expressing Effector Cells.
Klöß S; Oberschmidt O; Morgan M; Dahlke J; Arseniev L; Huppert V; Granzin M; Gardlowski T; Matthies N; Soltenborn S; Schambach A; Koehl U
Hum Gene Ther; 2017 Oct; 28(10):897-913. PubMed ID: 28810809
[TBL] [Abstract][Full Text] [Related]
23. Fully automated expansion and activation of clinical-grade natural killer cells for adoptive immunotherapy.
Granzin M; Soltenborn S; Müller S; Kollet J; Berg M; Cerwenka A; Childs RW; Huppert V
Cytotherapy; 2015 May; 17(5):621-32. PubMed ID: 25881519
[TBL] [Abstract][Full Text] [Related]
24. Immunoregulatory functions and therapeutic potential of natural killer cell-derived extracellular vesicles in chronic diseases.
He S; Su L; Hu H; Liu H; Xiong J; Gong X; Chi H; Wu Q; Yang G
Front Immunol; 2023; 14():1328094. PubMed ID: 38239346
[TBL] [Abstract][Full Text] [Related]
25. Enhanced extracellular vesicle production and ethanol-mediated vascularization bioactivity via a 3D-printed scaffold-perfusion bioreactor system.
Patel DB; Luthers CR; Lerman MJ; Fisher JP; Jay SM
Acta Biomater; 2019 Sep; 95():236-244. PubMed ID: 30471476
[TBL] [Abstract][Full Text] [Related]
26. Secreted Ligands of the NK Cell Receptor NKp30: B7-H6 Is in Contrast to BAG6 Only Marginally Released via Extracellular Vesicles.
Ponath V; Hoffmann N; Bergmann L; Mäder C; Alashkar Alhamwe B; Preußer C; Pogge von Strandmann E
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671836
[TBL] [Abstract][Full Text] [Related]
27. NKG2A and circulating extracellular vesicles are key regulators of natural killer cell activity in prostate cancer after prostatectomy.
Lu YC; Ho CH; Hong JH; Kuo MC; Liao YA; Jaw FS; Cheng JC; Huang CY; Chang KP; Chen CH; Lin JA; Hsiao A; Kung HN
Mol Oncol; 2023 Aug; 17(8):1613-1627. PubMed ID: 36931723
[TBL] [Abstract][Full Text] [Related]
28. Good manufacturing practice-compliant cell sorting and large-scale expansion of single KIR-positive alloreactive human natural killer cells for multiple infusions to leukemia patients.
Siegler U; Meyer-Monard S; Jörger S; Stern M; Tichelli A; Gratwohl A; Wodnar-Filipowicz A; Kalberer CP
Cytotherapy; 2010 Oct; 12(6):750-63. PubMed ID: 20491532
[TBL] [Abstract][Full Text] [Related]
29. CTLs, NK cells and NK-derived EVs against breast cancer.
Parsonidis P; Mamagkaki A; Papasotiriou I
Hum Immunol; 2023; 84(5-7):320-326. PubMed ID: 36925436
[TBL] [Abstract][Full Text] [Related]
30. iPSCs in NK Cell Manufacturing and NKEV Development.
Boyd-Gibbins N; Karagiannis P; Hwang DW; Kim SI
Front Immunol; 2022; 13():890894. PubMed ID: 35874677
[TBL] [Abstract][Full Text] [Related]
31. Clinical-grade generation of active NK cells from cord blood hematopoietic progenitor cells for immunotherapy using a closed-system culture process.
Spanholtz J; Preijers F; Tordoir M; Trilsbeek C; Paardekooper J; de Witte T; Schaap N; Dolstra H
PLoS One; 2011; 6(6):e20740. PubMed ID: 21698239
[TBL] [Abstract][Full Text] [Related]
32. High log-scale expansion of functional human natural killer cells from umbilical cord blood CD34-positive cells for adoptive cancer immunotherapy.
Spanholtz J; Tordoir M; Eissens D; Preijers F; van der Meer A; Joosten I; Schaap N; de Witte TM; Dolstra H
PLoS One; 2010 Feb; 5(2):e9221. PubMed ID: 20169160
[TBL] [Abstract][Full Text] [Related]
33. Comparison of characteristics and tumor targeting properties of extracellular vesicles derived from primary NK cells or NK-cell lines stimulated with IL-15 or IL-12/15/18.
Aarsund M; Segers FM; Wu Y; Inngjerdingen M
Cancer Immunol Immunother; 2022 Sep; 71(9):2227-2238. PubMed ID: 35119498
[TBL] [Abstract][Full Text] [Related]
34. An Improved Method to Produce Clinical-Scale Natural Killer Cells from Human Pluripotent Stem Cells.
Zhu H; Kaufman DS
Methods Mol Biol; 2019; 2048():107-119. PubMed ID: 31396935
[TBL] [Abstract][Full Text] [Related]
35. Characterization of stem cell factor gene-modified human natural killer cell line, NK-92 cells: implication in NK cell-based adoptive cellular immunotherapy.
Zhang J; Sun R; Wei H; Zhang J; Tian Z
Oncol Rep; 2004 May; 11(5):1097-106. PubMed ID: 15069553
[TBL] [Abstract][Full Text] [Related]
36. Interleukin-15-Stimulated Natural Killer Cells Clear HIV-1-Infected Cells following Latency Reversal
Garrido C; Abad-Fernandez M; Tuyishime M; Pollara JJ; Ferrari G; Soriano-Sarabia N; Margolis DM
J Virol; 2018 Jun; 92(12):. PubMed ID: 29593039
[TBL] [Abstract][Full Text] [Related]
37. Characterization of natural killer and natural killer-like T cells derived from ex vivo expanded and activated cord blood mononuclear cells: implications for adoptive cellular immunotherapy.
Ayello J; van de Ven C; Cairo E; Hochberg J; Baxi L; Satwani P; Cairo MS
Exp Hematol; 2009 Oct; 37(10):1216-29. PubMed ID: 19638292
[TBL] [Abstract][Full Text] [Related]
38. Chimeric antigen receptor (CAR)-modified natural killer cell-based immunotherapy and immunological synapse formation in cancer and HIV.
Liu D; Tian S; Zhang K; Xiong W; Lubaki NM; Chen Z; Han W
Protein Cell; 2017 Dec; 8(12):861-877. PubMed ID: 28488245
[TBL] [Abstract][Full Text] [Related]
39. Scalable Enrichment of Immunomodulatory Human Acute Myeloid Leukemia Cell Line-Derived Extracellular Vesicles.
Binder HM; Maeding N; Wolf M; Cronemberger Andrade A; Vari B; Krisch L; Gomes FG; Blöchl C; Muigg K; Poupardin R; Raninger AM; Heuser T; Obermayer A; Ebner-Peking P; Pleyer L; Greil R; Huber CG; Schallmoser K; Strunk D
Cells; 2021 Nov; 10(12):. PubMed ID: 34943829
[TBL] [Abstract][Full Text] [Related]
40. Artificial feeder cells expressing ligands for killer cell immunoglobulin-like receptors and CD94/NKG2A for expansion of functional primary natural killer cells with tolerance to self.
Michen S; Frosch J; Füssel M; Schackert G; Momburg F; Temme A
Cytotherapy; 2020 Jul; 22(7):354-368. PubMed ID: 32451262
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]